猪圆环病毒2d亚型衣壳蛋白在昆虫细胞中的表达

为了在昆虫细胞中表达猪圆环毒病2型(Porcine circovirus type 2,PCV2)衣壳蛋白,本研究设计合成引物从临床病料中扩增获得猪圆环病毒(Porcine circovirus,PCV)山东株衣壳蛋白基因缺失核定位区的序列,并进行序列分析.将该片段克隆到杆状病毒供体载体pFastBac-1上,然后转化大肠杆菌(Escherichia coli) DH 10-Bac感受态细胞,获得重组穿梭杆粒,将该杆粒转染到sf9昆虫细胞中,观察重组杆状病毒致细胞病变效应,并采用PCR、间接免疫荧光实验、十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(sodium dodecyl sulfate polyacrylamide gel electrophoresis,SDS-PAGE)和Western blot鉴定衣壳蛋白的表达情况.结果表明,扩增获得的猪圆环病毒山东株属于PCV2d亚型,与我国目前使用的商品化疫苗株(PCV2a及PCV2b亚型)在160～180 aa抗原位点有差异.成功构建了重组供体质粒pFastBac l-PCV2d-Cap和重组穿梭杆粒Bacmid-PCV2d-Cap,获得的重组杆状病毒在昆虫细胞中成功表达了约24 kD的PCV2d-Cap,该蛋白可以与猪圆环病毒阳性血清及His标签抗体发生反应,证明具有良好的反应原性.本研究是我国首次采用杆状病毒系统表达PCV2d亚型衣壳蛋白,为制备PCV2d亚单位疫苗以及酶联免疫吸附测定(enzyme linked immunosorbent assay,ELISA)试剂盒、防范PCV2d亚型流行提供了理论依据.     

Assessing the risks of releasing genetically modified virus insecticides: progress to date

Insect baculoviruses have been genetically modified to improve their speed of kill. Whilst these viruses show considerable promise for improving crop protection, any risks that might be attached to their wide-scale release need to be assessed. The potential hazards of releasing genetically modified baculoviruses are (i) negative effects on susceptible non-target species, and (ii) movement of the introduced gene. One approach to risk assessment is to estimate the relative fitness of the genetically modified virus as compared to the wild type. Initial laboratory and field experiments have shown that both productivity and transmission are significantly reduced in baculoviruses which express insect-selective toxins. This indicates that these viruses are likely to be less fit than the parent wild type. However, further information is needed on whether genetic modification alters baculovirus persistence and how baculoviruses behave in less susceptible species and species with different life history strategies.